Banque Pictet & Cie’s MacroGenics MGNX Stock Holding History

Banque Pictet & Cie’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-208,698	Closed	-$3.07M	–	337
2024 Q1	$3.07M	Buy	+208,698	New	+$3.15M	0.03%	178

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Banque Pictet & Cie's MGNX Position: Q2 2024 in Review

Banque Pictet & Cie sold out of MacroGenics (MGNX) in Q2 2024, closing a stake of 208,698 shares — an estimated $3.07M sold.

Banque Pictet & Cie first reported a position in MGNX in Q1 2024 and held it in 1 quarter. The position peaked at $3.07M in Q1 2024. 146 funds tracked by Wall St. Rank hold MGNX as of Q2 2024.

Banque Pictet & Cie reported no remaining MacroGenics position as of Q2 2024 after selling out during the quarter.
Banque Pictet & Cie sold 208,698 MacroGenics shares in Q2 2024, an estimated $3.07M.
Banque Pictet & Cie first reported a position in MacroGenics in Q1 2024 and held it in 1 quarter.
Banque Pictet & Cie's MacroGenics position peaked at $3.07M in Q1 2024.
146 funds tracked by Wall St. Rank held MacroGenics as of Q2 2024.

Based on Banque Pictet & Cie's 13F filing for Q2 2024, filed 25 Jul 2024.